Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library
T-cell activation without proliferation in juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation | ACS Nano
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor - ScienceDirect
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model? - Cytotherapy
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis - ScienceDirect
Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine
T-Cell Activation | Sartorius
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers | PLOS ONE
Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia | Nature Communications
JoF | Free Full-Text | Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis
Expression of the T cell activation markers HLA-DR and CD38 on... | Download Scientific Diagram
What does HLA-DR expression on CD4 T cells indicate? | Immunopaedia
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Frequency of activated CD4+ T cells across HIV-1 disease states. CD38... | Download Scientific Diagram
Early (CD69) and late (HLA-DR) activation marker expression by T cells... | Download Scientific Diagram
Considerations for cancer immunotherapy biomarker research during COVID-19 in: Endocrine-Related Cancer Volume 27 Issue 9 (2020)
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications
A Guide to Regulatory T Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency | SpringerLink
Cortisol Patterns Are Associated with T Cell Activation in HIV | PLOS ONE
